The global non-invasive cancer diagnostics market is witnessing remarkable growth as healthcare systems worldwide increasingly prioritize early cancer detection, precision medicine, and patient-friendly diagnostic solutions. According to recent market analysis, the market was valued at USD 138.5 Billion in 2025